Xenetic Biosciences, Inc. (XBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

2.7900-0.0900 (-3.13%)

As of 2:25PM EST. Market open.

Loading interactive chart...

ACCESSWIRE
Xenetic Biosciences, Inc. to Present at NobleCon17
FRAMINGHAM, MA / ACCESSWIRE / January 14, 2021 /Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at NobleCon17 - Noble Capital Markets' Seventeenth Annual Investor Conference on Tuesday, January 19, 2021 at 9:45 AM ET.
ACCESSWIRE
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
FRAMINGHAM, MA / ACCESSWIRE / January 5, 2021 / Xenetic Biosciences, Inc.
ACCESSWIRE
Xenetic Biosciences, Inc. Announces Closing of $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
FRAMINGHAM, MA / ACCESSWIRE / December 14, 2020 / Xenetic Biosciences, Inc.